vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $37.2M, roughly 1.9× GYRE THERAPEUTICS, INC.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -3.7%, a 21.0% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 25.4%). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 15.0%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
GYRE vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $70.6M |
| Net Profit | $-1.4M | $12.2M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | 29.3% |
| Net Margin | -3.7% | 17.3% |
| Revenue YoY | 33.4% | 25.4% |
| Net Profit YoY | -340.1% | 20.3% |
| EPS (diluted) | $-0.01 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $70.6M | ||
| Q3 25 | $30.6M | $58.7M | ||
| Q2 25 | $26.8M | $62.6M | ||
| Q1 25 | $22.1M | $63.0M | ||
| Q4 24 | $27.9M | $56.3M | ||
| Q3 24 | $25.5M | $53.3M | ||
| Q2 24 | $25.2M | $51.0M | ||
| Q1 24 | $27.2M | $53.3M |
| Q4 25 | $-1.4M | $12.2M | ||
| Q3 25 | $5.9M | $7.8M | ||
| Q2 25 | $1.6M | $11.1M | ||
| Q1 25 | $3.7M | $12.0M | ||
| Q4 24 | $569.0K | $10.1M | ||
| Q3 24 | $2.9M | $8.6M | ||
| Q2 24 | $4.5M | $7.1M | ||
| Q1 24 | $9.9M | $10.0M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | 29.3% | ||
| Q3 25 | 22.7% | 33.2% | ||
| Q2 25 | 8.1% | 31.1% | ||
| Q1 25 | 10.3% | 32.1% | ||
| Q4 24 | 2.4% | 32.8% | ||
| Q3 24 | 16.6% | 26.6% | ||
| Q2 24 | 12.7% | 24.3% | ||
| Q1 24 | 29.7% | 33.6% |
| Q4 25 | -3.7% | 17.3% | ||
| Q3 25 | 19.4% | 13.2% | ||
| Q2 25 | 5.9% | 17.7% | ||
| Q1 25 | 16.9% | 19.1% | ||
| Q4 24 | 2.0% | 18.0% | ||
| Q3 24 | 11.2% | 16.1% | ||
| Q2 24 | 18.0% | 13.9% | ||
| Q1 24 | 36.6% | 18.8% |
| Q4 25 | $-0.01 | $0.50 | ||
| Q3 25 | $0.03 | $0.32 | ||
| Q2 25 | $0.00 | $0.46 | ||
| Q1 25 | $0.00 | $0.50 | ||
| Q4 24 | $0.00 | $0.43 | ||
| Q3 24 | $0.01 | $0.37 | ||
| Q2 24 | $0.01 | $0.30 | ||
| Q1 24 | $0.03 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $106.0M | $408.6M |
| Total Assets | $166.1M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $136.3M | ||
| Q3 25 | $60.0M | $72.5M | ||
| Q2 25 | $54.4M | $110.4M | ||
| Q1 25 | $29.9M | $131.5M | ||
| Q4 24 | $26.7M | $98.2M | ||
| Q3 24 | $25.1M | $120.6M | ||
| Q2 24 | $25.1M | $87.7M | ||
| Q1 24 | $37.4M | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $106.0M | $408.6M | ||
| Q3 25 | $101.9M | $397.4M | ||
| Q2 25 | $92.0M | $389.9M | ||
| Q1 25 | $68.1M | $380.2M | ||
| Q4 24 | $63.3M | $370.2M | ||
| Q3 24 | $63.2M | $362.4M | ||
| Q2 24 | $60.4M | $354.0M | ||
| Q1 24 | $56.6M | $349.0M |
| Q4 25 | $166.1M | $3.0B | ||
| Q3 25 | $159.4M | $2.9B | ||
| Q2 25 | $152.6M | $2.9B | ||
| Q1 25 | $129.8M | $2.8B | ||
| Q4 24 | $125.4M | $2.9B | ||
| Q3 24 | $125.2M | $2.9B | ||
| Q2 24 | $120.9M | $2.8B | ||
| Q1 24 | $122.0M | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $126.3M |
| Free Cash FlowOCF − Capex | $-5.8M | — |
| FCF MarginFCF / Revenue | -15.5% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $126.3M | ||
| Q3 25 | $4.7M | $67.0M | ||
| Q2 25 | $2.1M | $-10.7M | ||
| Q1 25 | $-129.0K | $36.3M | ||
| Q4 24 | $-2.8M | $108.7M | ||
| Q3 24 | $1.7M | $24.6M | ||
| Q2 24 | $-5.5M | $27.6M | ||
| Q1 24 | $2.9M | $32.3M |
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -10.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -27.5% | — | ||
| Q1 24 | 9.8% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | 10.35× | ||
| Q3 25 | 0.79× | 8.63× | ||
| Q2 25 | 1.32× | -0.97× | ||
| Q1 25 | -0.03× | 3.02× | ||
| Q4 24 | -4.85× | 10.72× | ||
| Q3 24 | 0.60× | 2.86× | ||
| Q2 24 | -1.21× | 3.89× | ||
| Q1 24 | 0.29× | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
